Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in Eswatini.
Vambe D, Kay AW, Furin J, Howard AA, Dlamini T, Dlamini N, Shabangu A, Hassen F, Masuku S, Maha O, Wawa C, Mafukidze A, Altaye K, Sikhondze W, Gwitima T, Keus K, Simelane T, Kerschberger B.
Vambe D, et al. Among authors: dlamini t, dlamini n.
Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1095-1102. doi: 10.5588/ijtld.20.0082.
Int J Tuberc Lung Dis. 2020.
PMID: 33126945